Update on Anil Potti: A patient in a trial based on retracted research speaks out; Baggerly on how to prevent the next fiasco

A quick post this Sunday morning to draw your attention to two must-read items for anyone interested in the Anil Potti case or in how one goes about checking data. (A second paper by Potti et al was officially retracted on Friday.) First, a terrific profile of Joyce Shoffner in the Charlotte News & Observer. … Continue reading Update on Anil Potti: A patient in a trial based on retracted research speaks out; Baggerly on how to prevent the next fiasco

Paper by Silvia Bulfone-Paus to be retracted

At least one of the dominoes may be falling from a scandal at Research Center Borstel. Retraction Watch has learned that one of six papers that an investigation found to include data manipulation will be retracted by the Journal of Leukocyte Biology. The paper, “ATP induces P2X7 receptor-independent cytokine and chemokine expression through P2X1 and … Continue reading Paper by Silvia Bulfone-Paus to be retracted

Why was that paper retracted? Editor to Retraction Watch: “It’s none of your damn business”

Yesterday, we reported on the retraction of a 2004 study in the Annals of Thoracic Surgery. As we noted, the notice’s language was, um, fuzzy, referring vaguely to an investigation by the University of Florida, which uncovered instances of repetitious, tabulated data from previously published studies. Today, we are slightly more clear, although what we … Continue reading Why was that paper retracted? Editor to Retraction Watch: “It’s none of your damn business”

Top Retraction Watch posts of 2010, and a short wish list for 2011

2010 was a busy year at Retraction Watch. (Well, actually the first seven months of it weren’t busy at all, since we didn’t launch until August.) We’ve published 88 posts, an average of about four per week. We no longer wonder whether we’ll have enough material to post frequently, as Adam told The New York … Continue reading Top Retraction Watch posts of 2010, and a short wish list for 2011

Japanese virologist hit with publishing ban after widespread data manipulation

A leading Japanese virologist has received a 10-year publishing ban from the American Society of Microbiology after many of his published articles were found to have evidence of data manipulation. In its January 2011 issue, Infection and Immunity, an ASM title, is retracting five articles by the researcher, Naoki Mori, of the University of Ryukyus … Continue reading Japanese virologist hit with publishing ban after widespread data manipulation

Small problem: Nano-micro journal pulls diabetes paper with phony figure

Readers of this blog are aware that many of the retractions we’ve covered involve the misadventures of post-docs. That makes some superficial sense: post-docs, after all, are trainees, and therefore might be more likely to make mistakes. They’re also hungry to break into their chosen specialty, and how better to do that than by producing … Continue reading Small problem: Nano-micro journal pulls diabetes paper with phony figure

More on Anil Potti: Two other papers worth keeping an eye on

It’s fair to say that we haven’t heard the last of Anil Potti, the Duke cancer researcher who resigned last month following revelations that he had faked some of his results. Duke is still investigating the situation, and has also asked the Institute of Medicine to conduct its own study into the case and its … Continue reading More on Anil Potti: Two other papers worth keeping an eye on

Our computer ate the data: Expression of concern over blood thinner study raises concerns itself

Thrombosis and Haemostasis has issued an “expression of concern” over a 2004 paper by Tunisian researchers: Concerns have been raised by readers about the accuracy and validity of the data reported in the September 2004 article by Abdelkefi et al., entitled “Prevention of central venous line-related thrombosis by continuous infusion of low-dose unfractionated heparin, in … Continue reading Our computer ate the data: Expression of concern over blood thinner study raises concerns itself

Update on Ahluwalia fraud case: Researcher faked results, probably committed sabotage, says UCL

Earlier this month, we posted an item about the retraction of a 2004 Nature paper, “The large-conductance Ca2+-activated K+ channel is essential for innate immunity.” (That post was followed up with provocative comments from a researcher not affiliated with the authors, about what should happen to papers whose results can’t be replicated.) One of the … Continue reading Update on Ahluwalia fraud case: Researcher faked results, probably committed sabotage, says UCL

Do peer reviewers get worse with experience? Plus a poll

Peer review isn’t a core subject of this blog. We leave that to the likes of Nature’s Peer-to-Peer, or even the Dilbert Blog.  But it seems relevant to look at the peer review process for any clues about how retracted papers are making their way into press. We’re not here to defend peer review against … Continue reading Do peer reviewers get worse with experience? Plus a poll